Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

LivaNova to Present at the Barclays Global Healthcare Conference
LivaNova to Present at the Barclays Global Healthcare Conference


LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced Vladimir Makatsaria, Chief Executive Officer, will present in a fireside chat at the Barclays Global

EQS-Adhoc: BB Biotech AG publishes its 2024 annual report
EQS-Adhoc: BB Biotech AG publishes its 2024 annual report
EQS-Adhoc: BB Biotech AG publishes its 2024 annual report
EQS-News: Annual Report 2024: BB Biotech positions for structural sector recovery amid shifting market dynamics
EQS-News: Annual Report 2024: BB Biotech positions for structural sector recovery amid shifting market dynamics
EQS-News: Annual Report 2024: BB Biotech positions for structural sector recovery amid shifting market dynamics
ICON Reports Fourth Quarter and Full Year 2024 Results
ICON Reports Fourth Quarter and Full Year 2024 Results


ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today reported its financial results for the fourth quarter and full year ended December 31

Charles River Laboratories Announces Fourth-Quarter and Full-Year 2024 Results and Provides 2025 Guidance
Charles River Laboratories Announces Fourth-Quarter and Full-Year 2024 Results and Provides 2025 Guidance


Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the fourth quarter and full-year 2024 and provided guidance for 2025. For the quarter, revenue was $1.00

Premier, Inc. Enters Into $200 Million Accelerated Share Repurchase Program
Premier, Inc. Enters Into $200 Million Accelerated Share Repurchase Program


Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that it has entered into accelerated share repurchase agreements with JPMorgan Chase Bank

Chemed Corporation Declares Quarterly Dividend of 50 Cents
Chemed Corporation Declares Quarterly Dividend of 50 Cents


Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 50-cents per share on the Company’s capital stock, payable on March 14, 2025, to

Chemed To Report Fourth-Quarter 2024 Earnings February 26, Related Conference Call To Be Held On February 27
Chemed To Report Fourth-Quarter 2024 Earnings February 26, Related Conference Call To Be Held On February 27


Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the fourth quarter ended December 31, 2024, on Wednesday, February 26, 2025, following the close of trading

Charles River and Deciphex Extend Global Partnership to Expand Digital Pathology Offering with Exclusive Image Management Solutions
Charles River and Deciphex Extend Global Partnership to Expand Digital Pathology Offering with Exclusive Image Management Solutions


Charles River Laboratories International, Inc. (NYSE: CRL) and Deciphex, a leader in AI-powered digital pathology, today announced the next phase of a strategic collaboration to focus on advancing

Acadia Healthcare Announces Date for Fourth Quarter and Year-End 2024 Earnings Release
Acadia Healthcare Announces Date for Fourth Quarter and Year-End 2024 Earnings Release


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it will release its fourth quarter and year-end 2024 results on Thursday, February 27, 2025, after the close of the market

Premier Announces the 50 Top Cardiovascular Hospitals®
Premier Announces the 50 Top Cardiovascular Hospitals®


Premier, Inc. (NASDAQ: PINC), today announced the nation’s 50 Top Cardiovascular Hospitals® with the full list of recognized hospitals published in Fortune®.



To create the list, an objective

Premier, Inc. Reports Fiscal-Year 2025 Second-Quarter Results
Premier, Inc. Reports Fiscal-Year 2025 Second-Quarter Results


Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today reported financial results for the fiscal-year 2025 second quarter ended December 31, 2024.



On

ICON Portfolio of AI Tools Drives Clinical Trial Efficiencies
ICON Portfolio of AI Tools Drives Clinical Trial Efficiencies


ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced the expansion of its portfolio of artificial intelligence (AI) tools that

ICON plc Schedules Fourth Quarter and Full Year 2024 Earnings Conference Call
ICON plc Schedules Fourth Quarter and Full Year 2024 Earnings Conference Call


ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that it will release financial results for the fourth quarter and full year 2024

Charles River Laboratories Schedules Fourth-Quarter 2024 Earnings and 2025 Guidance Release and Conference Call
Charles River Laboratories Schedules Fourth-Quarter 2024 Earnings and 2025 Guidance Release and Conference Call


Charles River Laboratories International, Inc. (NYSE: CRL) will release fourth-quarter and full-year 2024 financial results and provide 2025 guidance on Wednesday, February 19th, before the market

EQS-News: BB Biotech: Preliminary full-year 2024 results and dividend proposal
EQS-News: BB Biotech: Preliminary full-year 2024 results and dividend proposal
EQS-News: BB Biotech: Preliminary full-year 2024 results and dividend proposal
EQS-Adhoc: BB Biotech AG closes the 2024 fiscal year with a profit
EQS-Adhoc: BB Biotech AG closes the 2024 fiscal year with a profit
EQS-Adhoc: BB Biotech AG closes the 2024 fiscal year with a profit
Premier, Inc. Declares Quarterly Cash Dividend
Premier, Inc. Declares Quarterly Cash Dividend


Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that its Board of Directors declared a cash dividend of $0.21 per share of Class A common

Edison issues report on BB Biotech (BION)
Edison issues report on BB Biotech (BION)
Edison issues report on BB Biotech (BION)
Novocure Inaugurates New Global Headquarters in Canton of Zug, Switzerland
Novocure Inaugurates New Global Headquarters in Canton of Zug, Switzerland


Novocure (NASDAQ: NVCR) announced today the official opening of its new global headquarters in the Canton of Zug, Switzerland. Novocure is an oncology company working to extend survival in some of

Novocure eröffnet neuen globalen Hauptsitz im Kanton Zug, Schweiz
Novocure eröffnet neuen globalen Hauptsitz im Kanton Zug, Schweiz


Novocure (NASDAQ: NVCR) gab heute die offizielle Eröffnung seines neuen globalen Hauptsitzes im Kanton Zug, Schweiz, bekannt. Novocure ist ein Onkologieunternehmen, das daran arbeitet, durch die

LivaNova to Announce Fourth-Quarter and Full-Year 2024 Results
LivaNova to Announce Fourth-Quarter and Full-Year 2024 Results


LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its fourth-quarter and full-year 2024 results on Tuesday, February 25, 2025 at 1

Charles River Expands Apollo™ Ecosystem, Offering Bespoke Client Experiences
Charles River Expands Apollo™ Ecosystem, Offering Bespoke Client Experiences


Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of Apollo™ for CRADL®, a secure cloud-based platform that enhances leading vivarium rental services through a

Premier, Inc. to Report Fiscal 2025 Second-Quarter Results and Host Conference Call on February 4, 2025
Premier, Inc. to Report Fiscal 2025 Second-Quarter Results and Host Conference Call on February 4, 2025


Premier, Inc. (NASDAQ: PINC) today announced that it will release financial results for its fiscal 2025 second quarter on Tuesday, February 4, 2025, at approximately 6:30 a.m. ET. The company will

Charles River and Akron Bio Announce Collaboration to Enhance Operations with Integration of CGMP Materials into Cell Therapy Platform
Charles River and Akron Bio Announce Collaboration to Enhance Operations with Integration of CGMP Materials into Cell Therapy Platform


Charles River Laboratories International, Inc. (NYSE: CRL) and Akron Bio (“Akron”), a leading supplier of critical materials and services for advanced therapies, today announced the integration of